We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > GBS

News List

US FDA adds new warning on J&J COVID-19 vaccine for Guillain-Barre´ syndrome expresspharma
July 14, 2021
It said J&J vaccine recipients should seek medical attention if they have symptoms including weakness or tingling sensations, difficulty walking or difficulty with facial movements.
MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS) b3cnewswire
January 22, 2019
MinervaX, a privately held Danish biotech company, announces today that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to ....
GenePOC introduces new molecular diagnostic test biospectrumasia
October 17, 2017
The test has been designed to identify streptococcus infection from direct vaginal or rectal swab samples at intrapartum.